186 related articles for article (PubMed ID: 16842062)
1. The common problem of rare disease in general practice.
Knight AW; Senior TP
Med J Aust; 2006 Jul; 185(2):82-3. PubMed ID: 16842062
[TBL] [Abstract][Full Text] [Related]
2. Rare diseases are a 'common' problem for clinicians.
Elliott E; Zurynski Y
Aust Fam Physician; 2015 Sep; 44(9):630-3. PubMed ID: 26488039
[TBL] [Abstract][Full Text] [Related]
3. Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data.
Groft SC; Posada de la Paz M
Adv Exp Med Biol; 2017; 1031():3-21. PubMed ID: 29214563
[TBL] [Abstract][Full Text] [Related]
4. Review of 11 national policies for rare diseases in the context of key patient needs.
Dharssi S; Wong-Rieger D; Harold M; Terry S
Orphanet J Rare Dis; 2017 Mar; 12(1):63. PubMed ID: 28359278
[TBL] [Abstract][Full Text] [Related]
5. The European Union Policy in the Field of Rare Diseases.
Moliner AM; Waligora J
Adv Exp Med Biol; 2017; 1031():561-587. PubMed ID: 29214592
[TBL] [Abstract][Full Text] [Related]
6. Rare disease registries: a call to action.
Lacaze P; Millis N; Fookes M; Zurynski Y; Jaffe A; Bellgard M; Winship I; McNeil J; Bittles AH
Intern Med J; 2017 Sep; 47(9):1075-1079. PubMed ID: 28891182
[TBL] [Abstract][Full Text] [Related]
7. Undiagnosed Diseases: Italy-US Collaboration and International Efforts to Tackle Rare and Common Diseases Lacking a Diagnosis.
Taruscio D; Floridia G; Salvatore M; Groft SC; Gahl WA
Adv Exp Med Biol; 2017; 1031():25-38. PubMed ID: 29214564
[TBL] [Abstract][Full Text] [Related]
8. Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review.
Anker MS; Holcomb R; Muscaritoli M; von Haehling S; Haverkamp W; Jatoi A; Morley JE; Strasser F; Landmesser U; Coats AJS; Anker SD
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):22-34. PubMed ID: 30920776
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of zebras in general practice: data from the Continuous Morbidity Registration Nijmegen.
van de Laar FA; Bor H; van de Lisdonk EH
Eur J Gen Pract; 2008; 14 Suppl 1():44-6. PubMed ID: 18949644
[TBL] [Abstract][Full Text] [Related]
10. [GPs: patients require you to doubt! Interview by Catherine Holué].
Viollet V
Rev Prat; 2012 Jan; 62(1):85-6. PubMed ID: 22335075
[No Abstract] [Full Text] [Related]
11. General knowledge and awareness on rare diseases among general practitioners in Bulgaria.
Miteva Ts; Jordanova R; Iskrov G; Stefanov R
Georgian Med News; 2011 Apr; (193):16-9. PubMed ID: 21617267
[TBL] [Abstract][Full Text] [Related]
12. Drugs for rare diseases: mixed assessment in Europe.
Prescrire Int; 2007 Feb; 16(87):36-42. PubMed ID: 17323539
[TBL] [Abstract][Full Text] [Related]
13. [Understanding the diagnostic delay in rare diseases].
Deden AC; Alma MA; Van Zelst-Stam WAG
Ned Tijdschr Geneeskd; 2020 Apr; 164():. PubMed ID: 32395952
[TBL] [Abstract][Full Text] [Related]
14. Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework.
Baynam G; Bowman F; Lister K; Walker CE; Pachter N; Goldblatt J; Boycott KM; Gahl WA; Kosaki K; Adachi T; Ishii K; Mahede T; McKenzie F; Townshend S; Slee J; Kiraly-Borri C; Vasudevan A; Hawkins A; Broley S; Schofield L; Verhoef H; Groza T; Zankl A; Robinson PN; Haendel M; Brudno M; Mattick JS; Dinger ME; Roscioli T; Cowley MJ; Olry A; Hanauer M; Alkuraya FS; Taruscio D; Posada de la Paz M; Lochmüller H; Bushby K; Thompson R; Hedley V; Lasko P; Mina K; Beilby J; Tifft C; Davis M; Laing NG; Julkowska D; Le Cam Y; Terry SF; Kaufmann P; Eerola I; Norstedt I; Rath A; Suematsu M; Groft SC; Austin CP; Draghia-Akli R; Weeramanthri TS; Molster C; Dawkins HJS
Adv Exp Med Biol; 2017; 1031():55-94. PubMed ID: 29214566
[TBL] [Abstract][Full Text] [Related]
15. Advocacy groups and their role in rare diseases research.
Dunkle M; Pines W; Saltonstall PL
Adv Exp Med Biol; 2010; 686():515-25. PubMed ID: 20824463
[TBL] [Abstract][Full Text] [Related]
16. [Hungarian national plan and strategy for rare diseases].
Kosztolányi G
Orv Hetil; 2014 Mar; 155(9):325-8. PubMed ID: 24566695
[TBL] [Abstract][Full Text] [Related]
17. Post-approval Studies for Rare Disease Treatments and Orphan Drugs.
Maier WC; Christensen RA; Anderson P
Adv Exp Med Biol; 2017; 1031():197-205. PubMed ID: 29214573
[TBL] [Abstract][Full Text] [Related]
18. Assessing the feasibility of a web-based registry for multiple orphan lung diseases: the Australasian Registry Network for Orphan Lung Disease (ARNOLD) experience.
Casamento K; Laverty A; Wilsher M; Twiss J; Gabbay E; Glaspole I; Jaffe A;
Orphanet J Rare Dis; 2016 Apr; 11():42. PubMed ID: 27090393
[TBL] [Abstract][Full Text] [Related]
19. National Organization for Rare Disorders (NORD): providing advocacy for people with rare disorders.
Putkowski S
NASN Sch Nurse; 2010 Jan; 25(1):38-41. PubMed ID: 20440954
[No Abstract] [Full Text] [Related]
20. Tackling rare diseases at European level: why do we need a harmonized framework?
Taruscio D; Trama A; Stefanov R
Folia Med (Plovdiv); 2007; 49(1-2):59-67. PubMed ID: 18018471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
